- Home
- TMTC vs XTNT Comparison
TMTC vs XTNT Comparison
Compare TMTC & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMTC
- XTNT
- Stock Information
- Founded
- TMTC 2021
- XTNT N/A
- Country
- TMTC United States
- XTNT United States
- Employees
- TMTC N/A
- XTNT N/A
- Industry
- TMTC Blank Checks
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TMTC Finance
- XTNT Health Care
- Exchange
- TMTC Nasdaq
- XTNT Nasdaq
- Market Cap
- TMTC 74.9M
- XTNT 74.1M
- IPO Year
- TMTC 2023
- XTNT N/A
- Fundamental
- Price
- TMTC $7.00
- XTNT $0.43
- Analyst Decision
- TMTC
- XTNT Strong Buy
- Analyst Count
- TMTC 0
- XTNT 1
- Target Price
- TMTC N/A
- XTNT $3.00
- AVG Volume (30 Days)
- TMTC 53.3K
- XTNT 82.6K
- Earning Date
- TMTC 01-01-0001
- XTNT 11-12-2024
- Dividend Yield
- TMTC N/A
- XTNT N/A
- EPS Growth
- TMTC 107.25
- XTNT N/A
- EPS
- TMTC 0.24
- XTNT N/A
- Revenue
- TMTC N/A
- XTNT $113,862,000.00
- Revenue This Year
- TMTC N/A
- XTNT $31.82
- Revenue Next Year
- TMTC N/A
- XTNT $13.64
- P/E Ratio
- TMTC $27.92
- XTNT N/A
- Revenue Growth
- TMTC N/A
- XTNT 45.11
- 52 Week Low
- TMTC $5.60
- XTNT $0.43
- 52 Week High
- TMTC $12.60
- XTNT $1.45
- Technical
- Relative Strength Index (RSI)
- TMTC 34.77
- XTNT 23.88
- Support Level
- TMTC $6.80
- XTNT $0.61
- Resistance Level
- TMTC $10.45
- XTNT $0.54
- Average True Range (ATR)
- TMTC 1.71
- XTNT 0.03
- MACD
- TMTC -0.09
- XTNT -0.01
- Stochastic Oscillator
- TMTC 24.73
- XTNT 0.00
About TMTC TMT Acquisition Corp
TMT Acquisition Corp is a newly organized blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.